The joint programme between Queen Mary University of London (QMUL) and Nanchang University (NCU) is comprised of a pre-clinical programme delivered in years 1-3 and a clinical programme delivered in years 4-5. The former is based on QMUL’s Biomedical Sciences BSc and NCU pre-clinical courses and the latter is based on the current clinical course at NCU.
Graduates will gain a Biomedical Sciences BSc from QMUL and a medical degree, Clinical Medicine (Biomedicine), from NCU, and will be registered to practice medicine in China.
The programme builds on the expertise and experience of the two universities and draws upon research strengths in population genetics, informatics, structural biology, cell biology, cancer, stem cell engineering, hypertension, genetics and gene therapy, cardiovascular and transplantation medicine.
All students will have the opportunity to come and study at Queen Mary between their second and third years. The best students also have the opportunity to complete their third year at Queen Mary University of London.
The combination of Chinese and British approaches to higher education with teaching from leading researchers at both universities means that students experience the following benefits:
This programme only admits Chinese nationals via the NCU application process. Most overseas admissions to NCU will continue to be admitted to their current programme. Students must score significantly above the top national line for admission to key universities in the Chinese national university entrance examination to be admitted onto the joint programme.